![Allan Frank Fischer Petersen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Allan Frank Fischer Petersen
Directeur/Membre du Conseil chez Biogen (Denmark) A/S
Profil
Allan Frank Fischer Petersen is currently a Director at Biogen (Denmark).
A since 2012.
He previously worked as the Chief Executive Officer at FUJIFILM Diosynth Biotechnologies Holdings Denmark ApS.
Postes actifs de Allan Frank Fischer Petersen
Sociétés | Poste | Début |
---|---|---|
Biogen (Denmark) A/S
![]() Biogen (Denmark) A/S BiotechnologyHealth Technology Biogen (Denmark) A/S manufactures therapies and pharmaceuticals. The company is headquartered in Glostrup, Denmark. | Directeur/Membre du Conseil | 10/04/2012 |
Anciens postes connus de Allan Frank Fischer Petersen
Sociétés | Poste | Fin |
---|---|---|
Biogen (Denmark) New Manufacturing ApS
![]() Biogen (Denmark) New Manufacturing ApS BiotechnologyHealth Technology Biogen (Denmark) New Manufacturing ApS engages in neuroscience. The firm offers therapies for multiple sclerosis, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis, as well as less common diseases such as spinal muscle atrophy, and progressive supranuclear palsy. The company was founded on July 1, 2008 and is headquartered in Hillerod, Denmark. | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Biogen (Denmark) A/S
![]() Biogen (Denmark) A/S BiotechnologyHealth Technology Biogen (Denmark) A/S manufactures therapies and pharmaceuticals. The company is headquartered in Glostrup, Denmark. | Health Technology |
Biogen (Denmark) New Manufacturing ApS
![]() Biogen (Denmark) New Manufacturing ApS BiotechnologyHealth Technology Biogen (Denmark) New Manufacturing ApS engages in neuroscience. The firm offers therapies for multiple sclerosis, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis, as well as less common diseases such as spinal muscle atrophy, and progressive supranuclear palsy. The company was founded on July 1, 2008 and is headquartered in Hillerod, Denmark. | Health Technology |